Cholamandalam Investment and Finance Company Ltd has reported a 183.9 per cent jump on its profit after tax for the quarter ending March 31, 2022 at Rs 690 crore, the company said on Friday.
The approval granted by the US Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) is for Pregabalin capsules of strengths 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg, the company said in a regulatory filing.
Among sectors, metal and realty indices fell 3 percent each, and the IT index was down 2 percent; however, the power index rose 0.5 percent. BSE midcap and smallcap indices fell 2 percent each.
